Serum Levels of Vascular Endothelial Growth Factor and Related Factors After Intravitreous Bevacizumab Injection for Retinopathy of Prematurity-Reference-Cited by-同舟云学术

Serum Levels of Vascular Endothelial Growth Factor and Related Factors After Intravitreous Bevacizumab Injection for Retinopathy of Prematurity

Published:2015-04-01 Issue:4 Volume:133 Page:391
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Wu Wei-Chi¹,Lien Reyin²,Liao Pei-Ju³,Wang Nan-Kai¹,Chen Yen-Po¹,Chao An-Ning¹,Chen Kuan-Jen¹,Chen Tun-Lu¹,Hwang Yih-Shiou¹,Lai Chi-Chun¹

Affiliation:

1. Department of Ophthalmology, Chang Gung Memorial Hospital, Guishan, Taoyuan, Taiwan2Department of Medicine, Chang Gung University, College of Medicine, Taoyuan, Taiwan

2. Department of Medicine, Chang Gung University, College of Medicine, Taoyuan, Taiwan3Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan

3. Department of Health Care Administration, Oriental Institute of Technology, New Taipei City, Taiwan5Department of Business Administration, National Taiwan University, Taipei, Taiwan

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating VEGF-A Levels in Relation to Retinopathy of Prematurity and Treatment Effects: A Systematic Review and Meta-Analysis;Ophthalmology Science;2024-11

2. Bevacizumab for Retinopathy of Prematurity is Not Associated With Systemic Hypertension;Journal of Pediatric Ophthalmology & Strabismus;2024-08-14

3. Relations between Neurocognitive Function and Visual Acuity: A Cross-Sessional Study in a Cohort of Premature Children;Children;2024-07-25

4. Aflibercept to treat retinopathy of prematurity: need for more research;Journal of Perinatology;2024-05-10

5. Targeting adenosine A2A receptors for early intervention of retinopathy of prematurity;Purinergic Signalling;2024-02-08